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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
22.06.20 Are men who 
smoke at 
higher risk for 
a more 
severe case 
of COVID-19 
than women 
who smoke? 
A Systematic 
Review 
medRxiv (non-
peer reviewed) | 
Article 
 Six cohorts from China 
were analysed and a 
crude odds ratio was 
manually calculated. 
 Results: Patients with a 
smoking history were 
approximately 2 times 
(95% CI= 1.036-1.883) 
as likely to suffer from 
severe clinical 
manifestations of 
COVID-19 compared to 
patients without a 
smoking history.  
smoking 
22.06.20 Management 
of patients 
with liver 
derangement 
during the 
COVID-19 
pandemic: an 
Asia-Pacific 
Lancet 
gastroenterology 
and hepatology | 
Review 
 It is common to 
encounter patients with 
COVID-19 with 
abnormal liver function, 
either in the form of 
hepatitis, cholestasis, or 
both. 
 Clinical scenarios 
covering the use of 
pharmacological 
treatment for COVID-19 
Liver, 
Asia-
Pacific 
2 
position 
statement 
in the case of liver 
derangement, and 
assessment and 
management of patients 
with chronic hepatitis B 
or hepatitis C, non-
alcoholic fatty liver 
disease, liver cirrhosis, 
and liver transplantation 
during the pandemic are 
discussed. 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
22.06.20 Estimation 
of fatality 
rate in 
Africa 
through 
the 
behavior 
of COVID-
19 in Italy 
relevance 
to age 
profiles 
medRxiv 
(non-peer 
reviewed) | 
Article 
 We compared the CFR 
observed in Italy with the age 
profiles in 46 Africa countries 
and 2 territories which are 
already confirmed COVID-19 
case.  
 The estimation of the CFR in 
Africa ranges between (1.0%-
5.4%) while in Italy is 10.1%. 
The five highest CFR countries 
and territories in Africa are 
Reunion (5.4%), Mauritius (5.1 
%), Tunisia (3.9%), Seychelles 
(3.8%) and Morocco (3.3%). 
The last three countries with 
low CFR are Uganda (1.0%), 
Zambia (1.1%) and Angola 
(1.1%). The observed 
difference is related to the age 
profiles. 
Africa, 
age 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
22.06.20 Assessment 
of 
Coronavirus 
Disease 
2019 
Community 
Jama 
 This retrospective case 
series included 7 
imported COVID-19 
cases and 800 
individuals at high risk. 
After the implementation 
of community measures, 
no locally acquired case 
Community 
containment,  
  
3 
Containment 
Strategies in 
Shenzhen, 
China 
of COVID-19 with indirect 
links to confirmed cases 
was identified in the 
community. 
 The findings of this study 
suggest that the 
implementation of 
community containment 
strategies by a 
multidisciplinary team 
may limit the community 
transmission of COVID-
19. 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
22.06.20 Genetic 
diversity 
among 
SARS-CoV2 
strains in 
South 
America 
may impact 
performance 
of Molecular 
detection 
medRxiv 
(non-peer 
reviewed) | 
Article 
 Results suggest that E-gene 
stands as the most conserved 
and reliable target when 
considering single-gene target 
testing for molecular diagnosis 
of SARS-CoV-2 in South 
America. 
South 
America, 
testing 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
23.06.2020 Effect of 
dexamethasone 
in hospitalized 
patients with 
COVID-19: 
preliminary 
report 
medRxiv 
(non-peer 
reviewed) | 
pre-print 
 RECOVERY 
preliminary results 
for the comparison 
of dexamethasone 
6mg given once 
daily for up to ten 
days vs usual care 
alone 
 Dexamethasone 
reduced 28-day 
mortality in 
hospitalised patients 
 dexamethasone 
4 
with C19 receiving 
invasive mechanical 
ventilation or 
oxygen at 
randomisation, but 
not among patients 
not receiving 
respiratory support 
 Trial was conducted 
in the UK but 
important to enable 
access of severe 
cases in LICs to 
dexamethasone as 
a treatment option 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
June 2020 Knowledge, 
attitudes 
and 
practices of 
COVID-19 
among 
income-
poor 
households 
in the 
Philippines: 
A cross-
sectional 
study 
Journal of 
Global Health 
 Objective of this study was to 
gain an understanding of how 
COVID-19 was perceived by 
households experiencing 
extreme poverty in the 
Philippines. 
 Conclusion: There is a need for 
targeted health education as a 
response strategy to COVID-19 
in low-income settings, and it is 
important that strategies are 
contextually relevant. 
Understanding KAPs among 
populations experiencing 
extreme poverty will be 
important as tailored guidance 
for public health response and 
communication strategies are 
developed for LMICs 
  
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
22.06.20 Children with COVID-19 at a specialist 
centre: initial experience and outcome 
Lancet Child & 
Adolescent Health 
| Correspondence  
Richard W 
Issitt, John 
Booth 
et al. 
22.06.20 Mini organs reveal how the coronavirus 
ravages the body 
Nature | news   
18.06.20 Africa: In The Fight Against  COVID-19, 
Africa is The Unsung Continent 
All Africa   
        
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
22.06.20 COVID-19 Safety 
Grades for 
Businesses—A 
Possible Mitigation 
Tool 
JAMA 
Health 
Forum 
 The trajectory of COVID-19 in the 
United States means no single 
public health solution, no matter 
how simple or complex, can 
eradicate this illness from our 
nation.  
 Therefore, we are left in a position 
that compels us to think creatively 
about developing pragmatic, 
rapidly deployable tools that will 
simultaneously allow for 
increased public autonomy and 
support disease mitigation during 
the next 18 to 24 months or until a 
vaccine becomes available. 
(these tools could also be used in 
LMICs) 
June 2020 COVID-19 
Considerations for 
Home and 
SSHAP 
Briefing 
 Many guidelines from low- and 
middle-income countries (LMICs) 
recognise the necessity to 
support home and community-
based care for COVID-19 (as 
deemed clinically appropriate, 
6 
Community-Based 
Care 
usually recommended only for 
‘mild’ disease) for reasons such 
as to protect capacity in formal 
health care settings and to reduce 
the risk of infection spread in 
health facilities. 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
      
Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Cochrane       
7 
Response 
Portal 
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
8 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
9 
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
10 
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
13 July 3:00 
PM – 6:00 
PM BST 
2020 UCL-Lancet 
Lecture: Global 
Health Preparedness 
by Dr Muhammad 
Pate, Global Director 
for Health, Nutrition 
and Population at the 
World Bank Group 
Online Lecture  2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership 
role in COVID-19 
vaccine development 
and access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard 
precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
11 
Available 
now 
COVID-19: 
Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
Online 
learning 
Multiple self-
paced 
course 
WHO 
12 
coronavirus disease 
outbreak 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple self-
paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
13 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
